HIV Antibody Production in African Patients
Author Information
Author(s): Lydie Beniguel, Evelyne Begaud, Fabrice Cognasse, Philippe Gabrié, Christophe D. Mbolidi, Mary A. Marovich, Celine Cazorla, Frederic Lucht, Christian Genin, Olivier Garraud
Primary Institution: GIMAP EA3064, Faculte de Medecine, Universite J. Monnet, St-Etienne, France
Hypothesis
Can drug-naive HIV-infected Africans produce functional antibodies despite high viral loads and concurrent infections?
Conclusion
The study found that drug-naive HIV-infected Africans can produce antibodies against HIV-1 antigens, indicating retained humoral immune responses.
Supporting Evidence
- PBMCs from drug-naive HIV-infected Africans produced IgG antibodies against ENV, GAG, and POL proteins.
- Antibody production was enhanced by the addition of cytokines IL-2 and IL-10.
- Spontaneous antibody production was observed in 12 out of 14 cultures without the need for specific antigen stimulation.
Takeaway
Even though these patients are sick with HIV, their bodies can still make some antibodies to fight the virus.
Methodology
The study involved culturing peripheral blood mononuclear cells from drug-naive HIV-infected Africans and testing their ability to produce antibodies in vitro.
Limitations
The study did not assess the long-term functionality of the antibodies produced or the impact of concurrent infections on antibody production.
Participant Demographics
Participants were drug-naive HIV-positive Africans, with a mean age of 30 years, and included both males and females.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website